Literature DB >> 9268341

The isolated RNase H domain of murine leukemia virus reverse transcriptase. Retention of activity with concomitant loss of specificity.

X Zhan1, R J Crouch.   

Abstract

Retroviral RNases H are similar in sequence and structure to Escherichia coli RNase HI and yet have differences in substrate specificities, metal ion requirements, and specific activities. Separation of reverse transcriptase (RT) into polymerase and RNase H domains yields an active RNase H from murine leukemia virus (MuLV) but an inactive human immunodeficiency virus (HIV) RNase H. The "handle region" present in E. coli RNase HI but absent in HIV RNase H contributes to the binding to its substrate and when inserted into HIV RNase H results in an active enzyme retaining some degree of specificity. Here, we show MuLV protein containing the C-terminal 175 amino acids with its own handle region or that of E. coli RNase HI has the same specific activity as the RNase H of RT, retains a preference for Mn2+ as the cation required for activity, and has association rate (KA) 10% that of E. coli RNase HI. However, with model substrates, specificities for removal of the tRNAPro primer and polypurine tract stability are lost, indicating specificity of RNase H of MuLV requires the remainder of the RT. Differences in KA, while significant, appear insufficient to account for the differences in specific activities of the bacterial and viral RNases H.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9268341     DOI: 10.1074/jbc.272.35.22023

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  A simple and rapid reverse transcriptase assay for the detection of retroviruses in cell cultures.

Authors:  H Kuno; H Ikeda; M Takeuchi; T Yoshida
Journal:  Cytotechnology       Date:  1999-05       Impact factor: 2.058

2.  Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA.

Authors:  S G Sarafianos; K Das; C Tantillo; A D Clark; J Ding; J M Whitcomb; P L Boyer; S H Hughes; E Arnold
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

3.  Molecular requirements for human immunodeficiency virus type 1 plus-strand transfer: analysis in reconstituted and endogenous reverse transcription systems.

Authors:  T Wu; J Guo; J Bess; L E Henderson; J G Levin
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

4.  Comparison of second-strand transfer requirements and RNase H cleavages catalyzed by human immunodeficiency virus type 1 reverse transcriptase (RT) and E478Q RT.

Authors:  C S Snyder; M J Roth
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

5.  Alternate polypurine tracts (PPTs) affect the rous sarcoma virus RNase H cleavage specificity and reveal a preferential cleavage following a GA dinucleotide sequence at the PPT-U3 junction.

Authors:  Kevin W Chang; John G Julias; W Gregory Alvord; Jangsuk Oh; Stephen H Hughes
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

6.  Multiple nucleotide preferences determine cleavage-site recognition by the HIV-1 and M-MuLV RNases H.

Authors:  Sharon J Schultz; Miaohua Zhang; James J Champoux
Journal:  J Mol Biol       Date:  2010-02-01       Impact factor: 5.469

Review 7.  Ribonuclease H: properties, substrate specificity and roles in retroviral reverse transcription.

Authors:  James J Champoux; Sharon J Schultz
Journal:  FEBS J       Date:  2009-02-18       Impact factor: 5.542

8.  R-loops promote trinucleotide repeat deletion through DNA base excision repair enzymatic activities.

Authors:  Eduardo E Laverde; Yanhao Lai; Fenfei Leng; Lata Balakrishnan; Catherine H Freudenreich; Yuan Liu
Journal:  J Biol Chem       Date:  2020-08-06       Impact factor: 5.157

9.  Sequence requirements for removal of tRNA by an isolated human immunodeficiency virus type 1 RNase H domain.

Authors:  C M Smith; O Leon; J S Smith; M J Roth
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

Review 10.  RNase H activity: structure, specificity, and function in reverse transcription.

Authors:  Sharon J Schultz; James J Champoux
Journal:  Virus Res       Date:  2008-02-07       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.